Related Experiment Videos
Regulatory T cells and allergic asthma.
1Inserm U454, CHU Arnaud de Villeneuve, 371 avenue Doyen Gaston Giraud, 34295 Montpellier cedex 5, France. yssel@montp.inserm.fr
Microbes and Infection
|September 21, 2001
Summary
Allergic asthma may stem from insufficient anti-inflammatory mechanisms. This study explores the potential of T regulatory cells and their factors as a therapeutic strategy for managing airway inflammation in asthma.
Area of Science:
- Immunology
- Respiratory Medicine
- Allergy Research
Background:
- Allergic asthma is characterized by significant airway inflammation.
- The underlying causes of asthma pathogenesis may involve a deficiency in natural immune suppressive and anti-inflammatory processes.
Purpose of the Study:
- To investigate the role of T regulatory cells in allergic asthma.
- To explore the therapeutic potential of T regulatory cells and their soluble factors for treating asthma.
Main Methods:
- Review of existing literature on T regulatory cells and asthma.
- Analysis of the mechanisms underlying T regulatory cell function in airway inflammation.
Main Results:
- T regulatory cells play a crucial role in immune suppression.
- Their soluble factors may possess significant anti-inflammatory properties relevant to asthma.
Conclusions:
- A deficit in immune regulatory mechanisms may contribute to asthma development.
- T regulatory cells and their secreted factors represent a promising avenue for novel asthma therapies.